Rinza (paracetamol, chlorpheniramine maleate, caffeine, phenylephrine hydrochloride) tablets №10


Symptomatic treatment of colds, flu and acute respiratory viral diseases (fever, pain, runny nose).



Composition and form of release
Rinza comes in tablets. Rinza is a combined preparation containing paracetamol, caffeine, phenylephrine hydrochloride and chlorpheniramine maleate.

Rinza is used to relieve the symptoms of fever in acute respiratory diseases, to relieve pain syndrome of various etiologies (attacks of toothache, neuralgia, myalgia, arthralgia, pain in trauma, migraine and burns). Also, the drug relieves the condition of patients and relieves nasal congestion in acute respiratory viral infections and allergic reactions – rhinitis, rhinopharyngitis, sinusitis. Also, the drug can be used as part of complex therapy in the treatment of inflammatory lesions of the paranasal sinuses.

Rinza is not used to treat patients suffering from hypersensitivity to any of the drug’s components, organic damage to the cardiovascular system, as well as myocardial infarction, glaucoma, insomnia, increased nervous excitability, convulsive seizures and epilepsy, severe forms of diabetes mellitus, thyroid diseases, and kidney dysfunction and liver, prostatic hypertrophy, children under 15, pregnant and lactating.

Application during pregnancy and lactation
Rinza is not used to treat nursing or pregnant women. If necessary, drug treatment becomes a question of stopping lactation.

Method of administration and dosage
When using the tablet form, Rinza is taken one tablet from 3 to 4 times a day, while the maximum single dose should not exceed 2 tablets at a time. Duration of treatment is 5 days.

Most often, Rinza’s treatment is well tolerated by patients, however, with excessive use of the drug, it is possible to develop digestive disorders, accompanied by nausea, vomiting, diarrhea, increased sweating, and some patients may experience rapid heartbeat and increased blood pressure. In severe forms of overdose, severe liver failure may occur. If a patient develops symptoms of an overdose, it is recommended to perform a gastric lavage and provide him with enterosorbents. As a specific therapy, the patient is administered SH-group donors; it is also possible to introduce precursors of the synthesis of glutathione-methionine and N-acetylcysteine.

Side effects
When Rinza is taken, some patients with individual hypersensitivity to the drug may experience nausea, pain in the stomach, diarrhea, increased heart rate and increased sweating.

Storage conditions and periods
Rinza is stored in a dry, dark place. The shelf life of the medicinal product does not exceed 3 years. It is not recommended to use the drug even in extreme cases after the end of its storage period.